Multicenter nomogram integrating clinicopathological features for prognosis in stage II-III deficient/microsatellite instability-high rectal cancer
World Journal of Clinical Oncology · 24.07.2026 · 17 (7)
DOI: 10.5306/wjco.122710 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.07.2026. Verfasst von De-Yao Zhang und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Lymphovascular invasion (LVI) and perineural invasion (PNI) are commonly used prognostic markers in colorectal cancer. Their clinical relevance in mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) rectal adenocarcinoma, however, has not been well defined. This study aimed to evaluate the prognostic impact of LVI and PNI in stage II-III dMMR/MSI-H rectal cancer patients. AIM To assess the prognostic value of LVI and PNI in stage II-III dMMR/MSI-H rectal adenocarcinoma and to develop a preliminary nomogram to predict recurrence risk. METHODS We retrospectively analyzed 107 treatment-naive patients with stage II-III dMMR/MSI-H rectal adenocarcinoma who underwent radical resection. LVI and PNI were assessed histopathologically, and their associations with clinicopathological features and recurrence-free survival (RFS) were analyzed using Cox regression and random forest modeling. A prognostic nomogram integrating tumor-node-metastasis stage, LVI, PNI, and body mass index was developed and validated. RESULTS LVI and PNI were identified in 21.5% (23/107) and 13.1% (14/107) of cases, respectively. In multivariable analysis, LVI remained independently associated with worse RFS (hazard ratio = 3.31, 95% confidence interval: 1.23-8.91, P = 0.018), while PNI showed a non-significant trend (hazard ratio = 1.75, P = 0.305). The nomogram showed favorable apparent discrimination for 1-, 3-, and 5-year RFS (area under the curves: 0.814, 0.871, and 0.862, respectively). CONCLUSION LVI is an independent prognostic factor in dMMR/MSI-H rectal cancer, while PNI is not. The proposed nomogram requires validation in larger prospective cohorts before clinical application.
Zitieren
APA
Zhang, D., Liao, Y., Tang, X., Chen, G., & Zhang, R. (2026). Multicenter nomogram integrating clinicopathological features for prognosis in stage II-III deficient/microsatellite instability-high rectal cancer. World Journal of Clinical Oncology, 17(7). https://doi.org/10.5306/wjco.122710
Vancouver
Zhang D, Liao Y, Tang X, Chen G, Zhang R. Multicenter nomogram integrating clinicopathological features for prognosis in stage II-III deficient/microsatellite instability-high rectal cancer. World Journal of Clinical Oncology. 2026;17(7). doi:10.5306/wjco.122710
BibTeX
@article{Zhang2026,
author = {Zhang, De-Yao and Liao, Yi-Jun and Tang, Xin and Chen, Gong and Zhang, Rong-Xin},
title = {Multicenter nomogram integrating clinicopathological features for prognosis in stage II-III deficient/microsatellite instability-high rectal cancer},
journal = {World Journal of Clinical Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.5306/wjco.122710}
}
EUVIMED